If you’re going to make a movie about fighters, you can’t skimp on the details. So says Talia Shire, an actress who knows a thing or two about the genre. “You notice everything,” Shire said during an ...

Shire nabbed FDA approval for its new long-acting ADHD drug, becoming the second drugmaker in two days to win a nod in that field. Shire’s drug, Mydayis, has been a long time coming. Previously known ...

When asked during a recent interview if she had any addictions, actress Jennifer Aniston admitted to just one: eye drops. That sounded familiar to Shire ($SHPG) execs ...

The rumors that Teva might attempt to buy Shire are puzzling because such an acquisition would present a huge internal conflict to the combined company: What to do with Shire's Vyvanse and Adderall XR ...

Mirum Pharmaceuticals has bought the rights to maralixibat from Shire and raised $120 million to take it into a pair of phase 3 trials next year. The deal reunites some of the management team and ...

After six months of relentless pursuit, Shire SHPG finally announced that it will acquire Baxalta, Inc. BXLT for $32 billion. The boards of directors of both companies have agreed to the merger. We ...

The history of one of the world's biggest speciality and rare disease pharmaceutical companies Shire is known as one of the world's fastest growing specialty pharmaceutical companies. Today, it has ...

Shire has announced plans to acquire dry eye specialist SARcode Bioscience with the aim of expanding its ophthalmics portfolio. Under the terms of the agreement, Shire will pay $160 million upfront ...

If there was ever a licensed property that feels right at home with a family-friendly farming simulator game, it’s The Lord of the Rings and author J.R.R. Tolkien’s iconic fantasy realm of ...